Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT03797729

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03797729
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03797729. Randomized; double masking; primary purpose treatment. Start 2019-05-14 (actual); primary completion 2021-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.
Condition
ST Elevation Myocardial Infarction
Intervention (Drug)
Tirofiban
Intervention (Drug)
Normal saline
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct03797729
Content hash
61248d5308c6b5d4d81ae88d6ae6a7af0a606ddf4dd43ea7163f4b819e4b450e